Your browser doesn't support javascript.
loading
Treatment Persistence in Atrial Fibrillation: The Next Major Hurdle.
Hylek, Elaine M.
Affiliation
  • Hylek EM; Department of Internal Medicine, Boston University, Boston, Massachusetts, United States.
Thromb Haemost ; 118(12): 2018-2019, 2018 Dec.
Article in En | MEDLINE | ID: mdl-30453349
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Warfarin / Dabigatran / Treatment Adherence and Compliance / Anticoagulants Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Thromb Haemost Year: 2018 Document type: Article Affiliation country: Estados Unidos Country of publication: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Warfarin / Dabigatran / Treatment Adherence and Compliance / Anticoagulants Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Thromb Haemost Year: 2018 Document type: Article Affiliation country: Estados Unidos Country of publication: Alemania